Total Payments
$282,689
2024 Payments
$15,708
Companies
95
Transactions
2,136
Medicare Patients
3,587
Medicare Billing
$415,419
Payment Breakdown by Category
Other$200,179 (70.8%)
Food & Beverage$33,297 (11.8%)
Consulting$27,515 (9.7%)
Travel$20,823 (7.4%)
Education$844.63 (0.3%)
Gifts$29.45 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $170,366 | 122 | 60.3% |
| Food and Beverage | $33,297 | 1,845 | 11.8% |
| Honoraria | $29,813 | 19 | 10.5% |
| Consulting Fee | $27,515 | 9 | 9.7% |
| Travel and Lodging | $20,823 | 114 | 7.4% |
| Education | $844.63 | 25 | 0.3% |
| Gift | $29.45 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $56,729 | 108 | $0 (2023) |
| SK Life Science, Inc. | $54,271 | 106 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $29,968 | 108 | $0 (2022) |
| ABBVIE INC. | $20,611 | 121 | $0 (2024) |
| Allergan, Inc. | $19,212 | 113 | $0 (2022) |
| Eisai Inc. | $17,970 | 57 | $0 (2024) |
| Neurelis, Inc. | $13,165 | 55 | $0 (2024) |
| UCB, Inc. | $12,787 | 101 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $11,090 | 14 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $10,678 | 41 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,708 | 330 | Eisai Inc. ($8,271) |
| 2023 | $17,056 | 251 | IDORSIA PHARMACEUTICALS US INC ($11,057) |
| 2022 | $30,425 | 240 | SK Life Science, Inc. ($12,900) |
| 2021 | $30,637 | 215 | SK Life Science, Inc. ($16,346) |
| 2020 | $69,804 | 224 | SK Life Science, Inc. ($24,778) |
| 2019 | $50,929 | 299 | Amgen Inc. ($37,460) |
| 2018 | $27,038 | 266 | UCB, Inc. ($9,252) |
| 2017 | $41,091 | 311 | Avanir Pharmaceuticals, Inc. ($19,700) |
All Payment Transactions
2,136 individual payment records from CMS Open Payments — Page 1 of 86
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: Immunology | ||||||
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Neurology | ||||||
| 12/19/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: EPILEPSY | ||||||
| 12/18/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $29.09 | General |
| 12/17/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Neurology | ||||||
| 12/16/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.52 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: Central Nervous System | ||||||
| 12/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/09/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $4.43 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.06 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: Central Nervous System | ||||||
| 12/03/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Immunology and Neurology | ||||||
| 12/03/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $12.13 | General |
| Category: Narcoplepsy | ||||||
| 12/02/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: NEUROLOGY | ||||||
| 12/02/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Neurology | ||||||
| 12/02/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: NEUROLOGY | ||||||
| 12/01/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/21/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $39.84 | General |
| Category: Immunology | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: PAIN | ||||||
| 11/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 681 | 1,027 | $193,909 | $81,131 |
| 2022 | 22 | 846 | 1,462 | $256,361 | $102,576 |
| 2021 | 21 | 956 | 1,432 | $272,624 | $123,557 |
| 2020 | 23 | 1,104 | 1,502 | $275,570 | $108,155 |
Total Patients
3,587
Total Services
5,423
Medicare Billing
$415,419
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 3 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 13 | 28 | $8,932 | $2,424 | 27.1% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2021 | 17 | 17 | $5,348 | $1,866 | 34.9% |
| 70551 | Mri scan brain | Office | 2021 | 16 | 16 | $13,921 | $1,798 | 12.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 15 | 17 | $2,040 | $964.75 | 47.3% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 12 | 13 | $2,275 | $883.52 | 38.8% |
| 96415 | Infusion of chemotherapy into a vein | Office | 2021 | 11 | 36 | $2,592 | $672.42 | 25.9% |
| 70450 | Ct scan head or brain | Office | 2021 | 11 | 11 | $3,993 | $532.20 | 13.3% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2021 | 11 | 11 | $1,221 | $506.00 | 41.4% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2021 | 12 | 108 | $1,890 | $455.19 | 24.1% |
| 99421 | Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes | Office | 2021 | 17 | 19 | $570.00 | $188.32 | 33.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 11 | 14 | $756.00 | $147.84 | 19.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 31 | 42 | $420.00 | $126.00 | 30.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 274 | 485 | $77,115 | $33,016 | 42.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 291 | 399 | $42,693 | $19,851 | 46.5% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2020 | 45 | 49 | $33,810 | $12,929 | 38.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 59 | 59 | $17,818 | $9,435 | 53.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 68 | 68 | $16,660 | $7,667 | 46.0% |
| 95957 | Digital analysis of electrical brain wave activity (eeg) | Office | 2020 | 25 | 26 | $17,004 | $5,196 | 30.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 50 | 54 | $11,556 | $4,831 | 41.8% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 11 | 42 | $13,398 | $2,654 | 19.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 28 | 33 | $5,775 | $2,405 | 41.6% |
| 70551 | Mri scan brain | Office | 2020 | 18 | 18 | $15,641 | $1,918 | 12.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 16 | 18 | $3,186 | $1,500 | 47.1% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2020 | 12 | 12 | $3,689 | $1,389 | 37.7% |
| 95908 | Nerve transmission studies, 3-4 studies | Office | 2020 | 14 | 14 | $3,738 | $1,290 | 34.5% |
About Dr. Andrew Braunstein, D.O
Dr. Andrew Braunstein, D.O is a Neurology healthcare provider based in Mooresville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1457343337.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Braunstein, D.O has received a total of $282,689 in payments from pharmaceutical and medical device companies, with $15,708 received in 2024. These payments were reported across 2,136 transactions from 95 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($170,366).
As a Medicare-enrolled provider, Braunstein has provided services to 3,587 Medicare beneficiaries, totaling 5,423 services with total Medicare billing of $415,419. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Mooresville, NC
- Active Since 08/17/2005
- Last Updated 07/30/2012
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1457343337
Products in Payments
- Aimovig (Biological) $56,526
- UBRELVY (Drug) $36,318
- XCOPRI (Drug) $34,123
- NUEDEXTA (Drug) $29,822
- Cenobamate (Drug) $19,266
- VALTOCO (Drug) $13,165
- Briviact (Drug) $12,132
- QUVIVIQ (Drug) $11,090
- Fycompa (Drug) $9,591
- APTIOM (Drug) $9,483
- Leqembi (Drug) $8,329
- OXTELLAR XR (Drug) $4,913
- APOKYN (Drug) $4,029
- TROKENDI XR (Drug) $3,451
- QULIPTA (Drug) $2,424
- ACTHAR (Biological) $2,236
- KYNMOBI (Drug) $1,299
- Austedo XR (Drug) $836.12
- TYSABRI (Biological) $799.17
- KESIMPTA (Drug) $749.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.